Use of an S1P receptor agonist
- 专利权人:
- Novartis AG
- 发明人:
- Tomic, Davorka Lucia,Haering, Dieter Adrian,Francis, Gordon
- 申请号:
- AU2015202061
- 公开号:
- AU2015202061A1
- 申请日:
- 2015.04.22
- 申请国别(地区):
- AU
- 年份:
- 2015
- 代理人:
- 摘要:
- #$%^&*AU2015202061A120151112.pdf#####The present invention relates to new uses of S1P receptor modulator or agonist such as fingolimod, for reducing or delaying the progression of brain damage, e.g. associated with MS.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- Imidazole derivatives as formyl peptide receptor modulators
- 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators
- Dosage regimen for a S1P receptor agonist
- Dosage regimen for a S1P receptor agonist
- Dosage regimen for a S1P receptor agonist